Prudential Financial
RCKT icon

Prudential Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

Prudential Financial’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.5K Buy
15,045
+870
+6% +$2.89K ﹤0.01% 2417
2026
Q1 		$50.7K Buy
+14,175
New +$56.3K ﹤0.01% 2314
2025
Q4 		– Sell
-10,260
Closed -$33.4K – 2397
2025
Q3 		$33.4K Buy
10,260
+95
+0.9% +$299 ﹤0.01% 2376
2025
Q2 		$24.9K Buy
+10,165
New +$51.5K ﹤0.01% 2389
2024
Q3 		– Sell
-102,705
Closed -$2.21M – 2783
2024
Q2 		$2.21M Sell
102,705
-58,925
-36% -$1.35M ﹤0.01% 1372
2024
Q1 		$4.35M Buy
161,630
+115,973
+254% +$3.29M 0.01% 995
2023
Q4 		$1.37M Buy
+45,657
New +$1.01M ﹤0.01% 1657
2023
Q3 		– Sell
-15,575
Closed -$225K – 2681
2023
Q2 		$225K Buy
+15,575
New +$315K ﹤0.01% 2401
2021
Q1 		– Sell
-3,910
Closed -$214K – 2525
2020
Q4 		$214K Buy
+3,910
New +$143K ﹤0.01% 2344

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Prudential Financial's RCKT Position: Q2 2026 in Review

Prudential Financial increased its Rocket Pharmaceuticals (RCKT) stake by 6.1% in Q2 2026, buying an estimated $2.89K and bringing the position to 15,045 shares worth $51.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Prudential Financial first reported a position in RCKT in Q4 2020 and has held it in 9 quarters since. The position peaked at $4.35M in Q1 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Prudential Financial held 15,045 shares of Rocket Pharmaceuticals worth $51.5K as of Q2 2026.
  • Prudential Financial bought 870 Rocket Pharmaceuticals shares in Q2 2026, an estimated $2.89K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2417 holding.
  • Prudential Financial first reported a position in Rocket Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
  • Prudential Financial's Rocket Pharmaceuticals position peaked at $4.35M in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.